Contract fill / finish services market for biologics market is projected to grow at an annualized rate of ~10%, <till 2030>

Roots Analysis has done a detailed study on Biologics Fill / Finish Services Market, 2019-2030., covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

 

To order this 480+ page report, which features 237 figures and 267 tables, please visit this - https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html

 

Key Market Insights

• Over 115 companies located in various regions across the globe claim to provide contract fill / finish services for various types of biopharmaceutical drug / therapy products
• The market landscape features a mix of both established players and new entrants; multiple biologics fill / finish service providers based in developed geographies have already adopted advanced fill / finish technologies
• Vials represent the most prominent form of packaging used for biopharmaceutical interventions; with increasing demand for self-administration devices, syringes have also garnered significant attention
• In fact, to acquire competencies across the value chain, stakeholders have actively invested in expanding their existing infrastructure and capabilities to cater to the evolving needs of both indigenous and international clients
• Over the past six years, the fill / finish services domain has also witnessed significant partnership activity, with companies building strategic business relationships to consolidate their positions in the market
• The outcome of consolidation is evident from our proprietary competitiveness analysis, based on several relevant parameters highlighting service and supplier strengths
• Presently, the installed global contract fill / finish capacity, across various geographies, is estimated to be over 17 million units (in term of packaging containers)
• The demand for contract fill / finish services for biologics is expected to increase in the coming years; it is likely that stakeholders will have to expand their respective capacities to ensure consistent supply
• We expect biopharmaceutical developers to continue to outsource their fill / finish operations in the short to mid-term, resulting in an annualized growth rate of more than 10%
• In the long-term, the projected opportunity is anticipated to be well distributed across various types of primary packaging, biological interventions and target disease indications

 

For more information, please visit https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html

 

Table of Contents

 

1.              PREFACE               

1.1.           Scope of the Report

1.2.           Research Methodology

1.3.           Chapter Outlines

 

2.              EXECUTIVE SUMMARY

 

3.              INTRODUCTION

3.1.           Chapter Overview

3.2.           Introduction to Biologics

3.3.           Need for Outsourcing Biologics-related Operations

3.4.           Introduction to Contract Manufacturing 

3.5.           Commonly Outsourced Operations in the Biopharmaceutical Industry

3.5.1.        Biologics Fill / Finish Operations

3.6.           Basic Guidelines for Selecting a Fill / Finish Service Provider

3.7.           Advantages of Outsourcing Fill / Finish Services

3.8.           Risks and Challenges of Outsourcing Fill / Finish Operations

 

4.              COMPETITIVE LANDSCAPE 

4.1.           Chapter Overview 

4.2.           Biologics Fill / Finish Service Providers: Overall Market Landscape

4.2.1.        Analysis by Year of Establishment 

4.2.2.        Analysis by Company Size

4.2.3.        Analysis by Location of Headquarters 

4.2.4.        Analysis by Location of Fill / Finish Facilities 

4.2.5.        Analysis by Type of Packaging

4.2.6.        Analysis by Additional Services Offered

4.2.7.        Analysis by Scale of Operation

4.2.8.        Analysis by Type of Biologics Filled

 

5.              COMPANY COMPETITIVENESS ANALYSIS

5.1.           Chapter Overview

5.2.           Methodology

5.3.           Assumptions and Key Input Parameters

 

5.4.           Competitiveness Analysis: Biologics Fill / Finish Service Providers in North America

5.4.1.        Companies Offering Fill / Finish Services for Ampoules

5.4.2.        Companies Offering Fill / Finish Services for Cartridges

5.4.3.        Companies Offering Fill / Finish Services for Syringes

5.4.4.        Companies Offering Fill / Finish Services for Vials

 

5.5.           Competitiveness Analysis: Fill / Finish Service Providers in Europe

5.5.1.        Companies Offering Fill / Finish Services for Ampoules

5.5.2.        Companies Offering Fill / Finish Services for Cartridges

5.5.3.        Companies Offering Fill / Finish Services for Syringes

5.5.4.        Companies Offering Fill / Finish Services for Vials

 

5.6.           Competitiveness Analysis: Fill / Finish Service Providers of Asia-Pacific

5.6.1.        Companies Offering Fill / Finish Services for Ampoules

5.6.2.        Companies Offering Fill / Finish Services for Cartridges

5.6.3.        Companies Offering Fill / Finish Services for Syringes

5.6.4.        Companies Offering Fill / Finish Services for Vials

 

6.              BIOLOGICS FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA: COMPANY PROFILES

6.1.           Chapter Overview

6.2.           Advanced BioScience Laboratories (ABL)

6.2.1.        Company Overview

6.2.2.        Service Portfolio

6.2.3.        Recent Developments

6.2.4.        Future Outlook

                

6.3.           Albany Molecular Research (AMRI)

6.3.1.        Company Overview

6.3.2.        Service Portfolio

6.3.3.        Financial Information

6.3.4.        Recent Developments

6.3.5.        Future Outlook

                

6.4.           BioPharma Solutions

6.4.1.        Company Overview

6.4.2.        Service Portfolio

6.4.3.        Financial Information

6.4.4.        Recent Developments

6.4.5.        Future Outlook

                

6.5.           BioReliance

6.5.1.        Company Overview

6.5.2.        Service Portfolio

6.5.3.        Financial Information

6.5.4.        Recent Developments

6.5.5.        Future Outlook

                

6.6.           Emergent BioSolutions

6.6.1.        C